Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)

Author:

Yiğit TalipORCID,Ata NaimORCID,Dinçer MuratORCID,Ülgü M. MahirORCID,Birinci ŞuayipORCID,Ayvalı M. OkanORCID

Abstract

AbstractExtensive research into dementia has more recently honed in on several key areas. These areas include the advancement of techniques such as the accumulation of amyloid-β and tau proteins, the monitoring of cerebral hypometabolism rates etc. The primary objective of this study is to explore the intricate interplay between Alzheimer's disease (AD)—other dementias (D) and various chronic illnesses in terms of time, intensity, and connectivity. In this context, we retrospectively examined data of 149,786 individuals aged 65 and above who received diagnoses of AD and D in the year 2020. At first, logistic regression (LR) analysis has been made with “sex”, “age” and “foreigner” (citizenship status) independent variables for AD and D. The LR models shows that while “sex” and “age” variables have a small rate on the risk of developing AD/D, it is detected that being a foreigner increase the risk of AD and D as 69.8% and 88.5% respectively. Besides, the LR models have middle-level success prediction rate for both of the two dependent variables. Additionally, we used the parallel coordinates graphs method within the R Studio to visualize their relationships and connections. The findings of this investigation strongly suggest that AD/D don’t stand as isolated conditions, but rather stem from intricate interactions and progressive processes involving diverse chronic diseases over time. Notably, ailments including hypertension, coronary artery disease, diabetes, hyperlipidemia, and psychological disorders, contribute substantially to the emergence of both AD and D. This study highlights that the fight against AD/D can only be possible with next-generation prophylactic interventions that can predict and manage risks. Such an approach holds the potential to potentially lower AD and dementia to levels that are amenable to treatment.

Publisher

Springer Science and Business Media LLC

Reference40 articles.

1. WHO. Dementia. [Online] 3 2023, 15. https://www.who.int/en/news-room/fact-sheets/detail/dementia.

2. European Alzheimer’s & Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration. Genetic associations between modifiable risk factors and Alzheimer disease. JAMA Netw. Open 6 (2023).

3. Adesuyan, M. et al. Antihypertensive agents and incident Alzheimer’s disease: A systematic review and meta-analysis of observational studies. J. Prev. Alz. Dis. 4, 715–724 (2022).

4. Ferrari-Souza, J. P., et al. Astrocyte biomarker signatures of amyloid-β and tau. Mol. Psychiat. 4781–4789 (2022).

5. Qin, J. et al. Prevalence of mild cognitive impairment in patients with. Hypertens. Res. 44, 1251–1260 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3